|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03378 HANXBIO-B
Nominal 
() | 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | |
| Turnover | 0 | -- | 0 |
| Cost of Sales | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | |
| Profit / (Loss) before Taxation | (122,820) | 31.467% | (93,423) | |
| Taxation | 5,898 | -28.622% | 8,263 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | |
| Non-controlling Interests | 1,092 | -88.005% | 9,104 | |
| Others | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (115,830) | 52.296% | (76,056) | |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 6,455 | -- | (1,845) |
| Depreciation & Amortisation | 5,479 | 426.321% | 1,041 |
| Directors' Emoluments | 14,849 | 1023.222% | 1,322 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | |
| EPS (cts) | -- | -- | -- |
| DPS (cts) | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- |
| NBV per share ($) | -- | -- | -- |
| Remarks: | Real time quote last updated: 18/12/2025 08:15 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -115,830 |
| %Change | 52.296% |
| EPS / (LPS) | RMB -- |
| NBV Per Share (¥) | RMB -- |